Autologous cord blood cell therapy for neonatal hypoxic-ischaemic encephalopathy: a pilot study for feasibility and safety

Autologous cord blood cell therapy for neonatal hypoxic-ischaemic encephalopathy: a pilot study for feasibility and safety

Abstract Neonatal hypoxic-ischaemic encephalopathy (HIE) is a serious condition; many survivors develop neurological impairments, including cerebral palsy and intellectual disability. Preclinical studies show that the systemic administration of umbilical cord blood cells (UCBCs) is beneficial for ne...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Masahiro Tsuji, Mariko Sawada, Shinichi Watabe, Hiroyuki Sano, Masayo Kanai, Emi Tanaka, Satoshi Ohnishi, Yoshiaki Sato, Hisanori Sobajima, Takashi Hamazaki, Rintaro Mori, Akira Oka, Hiroyuki Ichiba, Masahiro Hayakawa, Satoshi Kusuda, Masanori Tamura, Makoto Nabetani, Haruo Shintaku
Formato: Artigo
Lenguaje:inglés
Publicado: 2020
Acceso en línea:https://doi.org/10.1038/s41598-020-61311-9
https://www.nature.com/articles/s41598-020-61311-9.pdf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doi.org/10.1038/s41598-020-61311-9
https://www.nature.com/articles/s41598-020-61311-9.pdf

Ejemplares similares